Yao Cheng, Yu-Jie Zhai, Shao-Shuai Wang, Yan-Ying Fan
{"title":"Proton-Sensitive Receptors/Channels: Therapeutic Target for Ischemic Stroke, Focusing on Their Roles and Mechanisms.","authors":"Yao Cheng, Yu-Jie Zhai, Shao-Shuai Wang, Yan-Ying Fan","doi":"10.2174/011570159X381737250710050221","DOIUrl":null,"url":null,"abstract":"<p><p>Ischemic stroke is a common cerebrovascular disease. However, its pathophysiological mechanisms and therapeutic targets remain unclear. In physiological states, the brain maintains an acid-base balance through various mechanisms that are crucial for normal brain function. However, during cerebral ischemia, the disruption of this balance leads to acidosis of the ischemic brain tissue, primarily due to the interruption of energy supply and alterations in ion homeostasis. Studies have indicated that proton-sensitive receptors/channels, such as acid-sensing ion channels, protonsensitive G-protein-coupled receptors, and proton-activated chloride channels, exhibit distinct mechanisms in response to decreased pH. These targets are intricately linked to the pathophysiological processes, such as neuroprotection, neurorestoration, and neuroinflammation, underlying ischemic stroke. Recent studies have uncovered novel patterns of recognition, activation, subcellular distribution, and emerging functions of these proton-sensing receptors/channels, offering deeper insights into their roles and mechanisms in ischemic brain injury. This review summarizes the current insights regarding different contributions of these proton-sensing receptors/channels following ischemic stroke, and highlights the significance of targeting them for advancing novel therapeutic strategies for stroke intervention.</p>","PeriodicalId":10905,"journal":{"name":"Current Neuropharmacology","volume":" ","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Neuropharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/011570159X381737250710050221","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Ischemic stroke is a common cerebrovascular disease. However, its pathophysiological mechanisms and therapeutic targets remain unclear. In physiological states, the brain maintains an acid-base balance through various mechanisms that are crucial for normal brain function. However, during cerebral ischemia, the disruption of this balance leads to acidosis of the ischemic brain tissue, primarily due to the interruption of energy supply and alterations in ion homeostasis. Studies have indicated that proton-sensitive receptors/channels, such as acid-sensing ion channels, protonsensitive G-protein-coupled receptors, and proton-activated chloride channels, exhibit distinct mechanisms in response to decreased pH. These targets are intricately linked to the pathophysiological processes, such as neuroprotection, neurorestoration, and neuroinflammation, underlying ischemic stroke. Recent studies have uncovered novel patterns of recognition, activation, subcellular distribution, and emerging functions of these proton-sensing receptors/channels, offering deeper insights into their roles and mechanisms in ischemic brain injury. This review summarizes the current insights regarding different contributions of these proton-sensing receptors/channels following ischemic stroke, and highlights the significance of targeting them for advancing novel therapeutic strategies for stroke intervention.
期刊介绍:
Current Neuropharmacology aims to provide current, comprehensive/mini reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.
The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.